Octreotide and low-fat breast milk in postoperative chylothorax.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 15172311.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chylothorax is a rare complication following cavo-pulmonary connection and can lead to significant morbidity in infants and young children. We report here the case of a 3-month-old infant who underwent bilateral cavo-pulmonary connections, and developed severe chylothorax refractory to the usual conservative and surgical treatments. His chylothorax resolved after using a combination of parenteral octreotide (Sandostatin, Novartis Pharmaceuticals, East Hanover, NJ) and low-fat breast milk.
Medical subject headings
- Chylothorax
- Heart Bypass, Right
- Milk, Human
- Octreotide